| Theme 1 Publications |
|
|
|
Publications related to What 'package' of treatment and care services should be provided in different settings?
2009 - 2010Peer reviewed publicationsVan Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJC, Churchyard GJ, Grant AD (2010) Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settings. AIDS 2010; 24:1051-5.(.doc Lewis J, Charalambous S, Day JH, Fielding KL, Grant AD, Hayes RJ, Corbett EL. Churchyard GJ. (2009) HIV infection does not affect active case finding of tuberculosis in South African gold miners . Am Rev Respir Crit Care Med 2009;180:1271-8. Hoffmann CJ, Charalambous S, Sim J, Ledwaba J, Schwikkard G, Chaisson RE, Fielding K, Churchyard G, Morris L, Grant AD. (2009) Viremia, resuppression, and accumulation of resistance in HIV subtype C during first-line antiretroviral therapy in South Africa. Clin Infect Dis 2009;49:1928-35. R Weigel et al (2009) Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights BMC Pediatrics 2009, 9:45 doi:10.1186/1471-2431-9-4 R Weigel et al (2009) Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre- post comparison BMC Pediatrics 2009 , 9:80 doi:10.1186/1471-2431-9-80 S Phiri et al (2010) Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi Sex Transm Infect published online doi: 10.1136/sti.2009.041814 Sahay S, Ghate M, Mehendale SM. (2009) Managing HIV therapy literacy in resource limited setting. HIV therapy ; Vol 3 (4)2009; IBN 1758 – 4310 [In press] Kielmann K, Cataldo F. (2010) Tracking the model 'citizen' in evolving conceptions of the patient AIDS CARE Bonell CP, Hargreaves JR, Cousens SN, Ross DA, Hayes RJ, Petticrew M, Kirkwood B (2009) Alternatives to randomisation in the evaluation of public-health interventions: design challenges and solutions , J Epidemiol Community Health 2009;0:doi:10.1136/jech.2008.082602 Everett DB, Baisley K, Changalucha J, Vallely A, Watson-Jones D, Cook C, Knight L, Ross DA, Mugeye K, McCormack S, Lacey CJ, Jentsch U, Hayes RJ (2009) Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings , J Clin Micro 2009;47:1058-1062 Book ChaptersAlison Grant, Kevin De Cock 2008 (2010) Oxford Textbook of Medicine, HIV in the developing world. Cataldo, F. (2009) Pharmaceuticals and Society: Critical Discourses & Debates (Williams, Gabe, Davis, Eds.), 14th Sociology of Health and Illness Monograph, Blackwell London, New Forms of Citizenship and Socio-political Inclusion: Accessing Antiretroviral Treatment in a favela. Policy BriefsMRC/UVRI and Evidence for Action: Partner Focus May 2010 Research Programme ReportsBenson Droti, July-Sept 2008; Oct-Dec 2008; January-March 2009, Wakiso project progress reports. Cataldo F.,Kielmann K.,Musheke M. Jan 2010, New challenges for home-based care providers in the context of ART rollout in Zambia. 2008-2009Peer reviewed publicationsSAHAY S, G. M., MEHENDALE SM (2009) Managing HIV therapy literacy in resource limited setting . HIV Therapy, 3.SHAMANESH M, C. F., WAYAL S (2008) The burden and determinants of HIV and sexually transmitted infections in a population-based sample of female sex workers in Goa, India . Sexually Transmitted Infections, 85, 50-59. SHAMANESH M, P. V., MABEY D (2008) Effectiveness of interventions for the prevention of HIV and other sexually transmitted infections in resource-poor setting: a systematic review. Tropical Medicine and International Health , 8, 659-679. KULKARNI S, T. S., GANGAKHEDKAR R, JADHAV S (2008) Neutralizing antibody responses in recent seroconverters with HIV-1 subtype C infections in India . AIDS Res Hum Retroviruses., 24, 1159-66. SINGH, H. K., GUPTA, AMITA; SIBERRY, (2008) The Indian Pediatric HIV Epidemic: A Systematic Review Current HIV Research, 6, 419-432(14). LALL M, G. R., SEN S, KAPILA K, TRIPATHY S, PARANJAPE RS (2008) Profile of Primary Resistance in HIV-1-Infected Treatment-Naive Individuals from Western India. AIDS Research and Human Retroviruses, 24, 987-990.
Book chaptersPriority Interventions: HIV/AIDS Prevention, Treatment and Care in the Health Sector 2007 - 2008Policy BriefsHoskins, S and South A. Cost-effective prevention of HIV-related opportunisic infection 2008. 2007-2008Peer reviewed publications Walzer PD, Evans HER, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients. Clinical Infectious Disease 2008 Feb 15; 46(4): 625-33 Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, Grant AD. "That is why I stopped the ART": Patients' and providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health 2008 Feb 18; 8:63 (240kb PDF) Pemba L, Charalambous S, von Gottberg A, Magadla B, Moloi V, Seabi O, Wasas A, Klugman K, Chaisson RE, Fielding KL, Churchyard GJ, Grant AD. Impact of cotrimoxazole prophylaxis on antimicrobial resistance in carriage isolates of Streptococcus pneumoniae among HIV-infected mineworkers in South Africa. J Infect 2008 Mar; 56(3): 171-8. Epub 2008 Feb 8 Hoffman CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS 2008 Jan 2; 22(1): 67-74 Arenas Pinto A, Grant AD, Dunn D, Carr A, Reiss P, Edwards S, Lundgren J, Overton T, Martinez E, Copas A, Chan P, Weber R, Bhaskaran K, Weller I. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-infected adults exposed to anti-retroviral therapy: An international case-control study. AIDS 2007 Nov 30; 21(18): 2455-64 Churchyard GJ, Scano F, Grant AD, Chaisson RE. TB preventive therapy in the era of HIV infection: Overview and research priorities. The Journal of Infectious Diseases 2007 July 1 supp; 196: S52–S62 Hoffmann C, Charalambous S, Thio CL, Martin DJ, Pemba L, Fielding KL, Churchyard GJ, Chaisson RE, Grant AD. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS 2007 Jun; 21(10): 1301-1308 Charalambous S, Innes C, Muirhead D, Kumaranayake L, Fielding K, Pemba L, Hamilton R, Grant A, Churchyard GJ. Evaluation of a Workplace HIV Treatment Programme in South Africa. AIDS. 2007 Jul; 21 Suppl 3:S73-8. Reid AJ, Stohr W, Walker AS, Williams IG, Kityo C, Hughes P, Kambugu A,Gilks CF, Mugyenyi P, Munderi P, Hakim J, Gibb DM. Severe renal dysfunction and risk factors associated with renal impairment in adults with HIV infection in Africa initiating Antiretroviral Therapy. Clinical Infectious Diseases 2008; 46: 1271–1281 DART Trial Team. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD<200 cells/mm3 . AIDS 2008 Jan 11; 22(2): 237-247 DART trial Team. 24 week safety and tolerability of Nevirapine versus Abacavir in combination with Zidovudine/Lamivudine as first-line antiretroviral therapy: A randomised double-blind trial (NORA) . TMIH 2008; 13(1): 6–16. Epub Feb 17 Makombe S, Jahn A, Tweya H et al. A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival . WHO Bulletin 2007; 85(11): 851-7 Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the World Health Organization criteria for antiretroviral treatment failure among adults in South Africa . AIDS 2008 Oct 1; 22(15): 1971-1977 Fielding KL, Charalambous S, Stenson A, Pemba L, Martin D, Wood R, Churchyard GJ, Grant AD. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study. BMC Infectious Diseases 2008; 8:93 2006 - 2007Sen, S, Tripathy SP, Paranjape RS. Antiviral drug resistance testing. J Postgrad Med 2006; 52: 187-93 Sahay S, Phadke M, Brahme R,, Paralikar V, Joshi V, Suvarne S, Risbud A, Mate S, Mehendale S. Correlates of Anxiety and depression among HIV test-seekers at a VCTC facility in Pune, India. Quality of Life Research 2007 Feb; 16 (1): 41-52 Mawar N. Joshi PL, Sahay S, Bagul RD, Paranjape R, 2007: Concerns and experiences of women participating in short term AZT intervention feasibility study for PMTCT. Culture, Health & Sexuality 2007 Mar; 9(2): 199-207 Seema Sahay, Yasmeen Shaikh, Mrudula Phadke, Kathleeen MacQueen, Neelam Joglekar, Robert C Bollinger, Sanjay Mehendale: Understanding the community correlates of standard of care for conducting vaginal microbicide clinical trial in India. AIDS and Behaviour Brown M, Miiro G, Nkurunziza P, Watera C, Quigley MA, Dunne DW, Whitworth JAG, Elliott AM, 2006: Schistosoma mansoni, nematode infections and progression to active tuberculosis among HIV-1-infected Ugandans. Culture, Health & Sexuality 2007 Mar; 9(2): 199-207 Watera C, Whitworth JAG, Muwonge R, Todd J, Nakiyingi J, Brink A, Miiro G, Antvelink L, Kamali A, French N and Mermin J, 2006: Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1- infected adults attending an HIV/AIDS clinic in Uganda. J AIDS 2006; 42(3): 373-8 Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. Editorial review. J AIDS 2006; 42(3): 373-8 Mshana G, Wamoyi J, Busza J, Zaba B, Urassa M. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national programme. AIDS Patient Care STDS 2006; 20(9): 649-57 Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, Gibb DM and the CHAP Trial Team. Determinants of Survival without Antiretroviral Therapy after Infancy in HIV-1 Infected African Children in the CHAP Trial. J AIDS 2006; 42: 637-645 Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, Sinyinza F, Lishimpi K, Nunn A, Gillespie S, Zumla A, Chintu C, Gibb DM and the CHAP Trial Team. Effect of Cotrimoxizole on Causes of Death, Hospital admissions and antibiotic use in HIV-infected children in the CHAP trial. AIDS 2006; 21: 77-84 Dunn DT, Gibb DM, Duong T for the HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS). Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1 infected children. AIDS 2006; 20: 1289-1294 Walker AS, Mulenga V, Ford D, Kabamba K, Sinyinza F, Kankasa C, Chintu C, Gibb DM and the CHAP Team. The Impact of Cotrimoxazole Prophylaxis and Antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clinical Infectious Diseases 2007; 44 (10): 1361-1367
Book ChaptersHelen Ayles, Peter Godfrey-Faussett, Nolda Beyers, Don Emerson, Editor: Stefan Kaufmann: Surveillance studies and interpretation in TB handbook (vol.3)
|



